Computer Training Program for Younger Patients With a Brain Tumor Who Underwent Radiation Therapy (NCT01503086) | Clinical Trial Compass
CompletedNot Applicable
Computer Training Program for Younger Patients With a Brain Tumor Who Underwent Radiation Therapy
United States, Canada45 participantsStarted 2014-07-30
Plain-language summary
This randomized clinical trial studies how well an adaptive computerized cognitive training program works compared to a non-adaptive computerized cognitive training program in treating younger patients with brain tumor who underwent radiation therapy. Providing a computer training program may improve the well-being and quality of life of patients with cognitive (physical and mental) function difficulties caused by radiation therapy to the brain.
Who can participate
Age range
6 Years – 16 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Patient must be newly diagnosed or relapsed/progressed with a brain tumor that has not previously been treated with CRT
* Note: COG therapeutic study participation is not required for ACCL10P1 enrollment
* Patient enrollment must occur within 4 calendar months following completion of CRT
* Reminder: after patient enrollment, baseline testing followed by randomization must occur within 2-4 months after completion of CRT
* The patient must have an identified caregiver who is willing and able to oversee the training practice during the intervention period (ie, for 5-9 weeks starting approximately 3 months after completion of CRT)
* The patient must have access to a telephone and phone number where they can be reached
* The patient and caregiver must have reading, speaking and listening comprehension of English
* All patients and/or their parents or legal guardians must sign a written informed consent (patient assent is also recommended when applicable according to each institution's policy)
* All institutional, Food and Drug Administration (FDA), and National Cancer Institute (NCI) requirements for human studies must be met
Exclusion Criteria:
* Patients with pontine glioma are not eligible
* Patients with an estimated survival of less than one year are not eligible
* Patients with a history of traumatic brain injury prior to tumor diagnosis are not eligible
* Patients with a motor, visual, or auditory handicap that prevents computer use (e.g., unr…
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.